SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 79.95 |
Enterprise Value ($M) | 5.23 |
Book Value ($M) | 81.12 |
Book Value / Share | 2.81 |
Price / Book | 0.99 |
NCAV ($M) | 78.76 |
NCAV / Share | 2.73 |
Price / NCAV | 1.02 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.57 |
Return on Assets (ROA) | -0.36 |
Return on Equity (ROE) | -0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.35 |
Current Ratio | 9.35 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 89.94 |
Assets | 92.31 |
Liabilities | 11.19 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | StemPoint Capital LP | 8.20 | ||
13G/A | Great Point Partners Llc | 6.88 | -24.69 | |
13G/A | Biotechnology Value Fund L P | 9.97 | 11.06 | |
13G/A | Nantahala Capital Management, LLC | 9.99 | 1.31 | |
13G/A | Citadel Advisors Llc | 4.20 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
22,425 | 59,221 | 37.87 | |
107,279 | 203,186 | 52.80 | |
26,100 | 101,945 | 25.60 | |
26,351 | 109,357 | 24.10 | |
35,033 | 136,802 | 25.61 | |
(click for more detail) |
Similar Companies | |
---|---|
VKTX – Viking Therapeutics, Inc. | VRPX – Virpax Pharmaceuticals, Inc. |
VSTM – Verastem, Inc. | VTVT – vTv Therapeutics Inc. |
VXRT – Vaxart, Inc. |
Financial data and stock pages provided by
Fintel.io